CIK 0001888886 · Large accelerated filer
Structure Therapeutics Inc.
Sign in to watch- Ticker
- GPCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981480821
- Phone
- (650) 457-1978
- Business address
- 601 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- ShouTi Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Option exercise | +99,999 | $0.39 | $39K | 743,345 |
| 2024-06-12 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Option exercise | +50,001 | $0.48 | $24K | 793,346 |
| 2024-06-12 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Option exercise · Share Option (right to buy) | −99,999 | 1 | ||
| 2024-06-12 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Option exercise · Share Option (right to buy) | −50,001 | 488,766 | ||
| 2024-06-10 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Conversion | −555,000 | 643,346 | ||
| 2024-06-10 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Conversion · American Depositary Shares | +185,000 | 185,000 | ||
| 2024-06-10 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Sale · American Depositary Shares | −185,000 | $52.80 | $9.8M | 0 |
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +106,200 | $0.34 | $36K | 191,907 |
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion 10b5-1 | −106,200 | 85,707 | ||
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise · Share Option (right to buy) 10b5-1 | −106,200 | 213,800 | ||
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion · American Depositary Shares 10b5-1 | +35,400 | 35,400 | ||
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −17,700 | $45.00 | $797K | 17,700 |
| 2024-06-03 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −17,700 | $50.00 | $885K | 0 |
| 2024-05-20 | Yoon Jun CHIEF FINANCIAL OFFICER | Grant or award · American Depositary Shares | +694 | 1,294 | ||
| 2024-03-15 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (right to buy) | +213,486 | 213,486 | ||
| 2024-03-15 | Bach Mark Allen CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +65,352 | 65,352 | ||
| 2024-03-15 | Ma Yingli CHIEF TECHNOLOGY OFFICER | Grant or award · Stock Option (right to buy) | +91,494 | 91,494 | ||
| 2024-03-15 | Yoon Jun CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +148,134 | 148,134 | ||
| 2024-03-15 | Stevens Raymond C CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +335,481 | 335,481 | ||
| 2024-03-15 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Grant or award | +85,707 | 85,707 |
Page 8 of 12 · 233 trades